Study ID (Protocol Number)
AI424-452
 
STUDY LOCATIONS*


 




*Not all study site locations may be listed - please check back soon for updated
information. For more information regarding other participating countries, please
visit clinicaltrials.gov.
  STUDY NAME
Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
STUDY OVERVIEW
The purpose of AI424452 is to collect safety clinical data in human immunodeficiency virus (HIV) infected pediatric subjects ≥ 6 years to < 18 years of age and ≥ 15 kg who are receiving Atazanavir (ATV) capsule boosted with Ritonavir (RTV) capsule or tablet formulations and an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone therapy as part of their Antiretroviral (ARV) regimen.
 

 
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.
Find A Study